ABHD14A-ACY1
Basic information
Region (hg38): 3:51974706-51989183
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (105 variants)
- Inborn genetic diseases (40 variants)
- Aminoacylase 1 deficiency (24 variants)
- not specified (7 variants)
- Intellectual disability (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD14A-ACY1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 29 | ||||
missense | 65 | 12 | 79 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 13 | |||||
splice region | 0 | |||||
non coding | 23 | |||||
Total | 5 | 3 | 84 | 51 | 9 |
Highest pathogenic variant AF is 0.0000131
Variants in ABHD14A-ACY1
This is a list of pathogenic ClinVar variants found in the ABHD14A-ACY1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-51975142-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
3-51975164-T-G | not specified | Uncertain significance (Jan 08, 2024) | ||
3-51975197-T-G | not specified | Uncertain significance (Dec 16, 2022) | ||
3-51975203-C-G | not specified | Uncertain significance (Apr 12, 2022) | ||
3-51977880-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
3-51977899-C-T | not specified | Uncertain significance (Apr 17, 2024) | ||
3-51977916-G-C | not specified | Uncertain significance (Mar 14, 2023) | ||
3-51977925-C-G | not specified | Uncertain significance (Nov 17, 2023) | ||
3-51977934-A-G | not specified | Uncertain significance (Jan 03, 2022) | ||
3-51977962-G-A | not specified | Uncertain significance (Aug 22, 2023) | ||
3-51978001-A-G | not specified | Uncertain significance (Aug 04, 2021) | ||
3-51978071-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
3-51978310-G-T | not specified | Uncertain significance (Oct 04, 2022) | ||
3-51978314-C-G | not specified | Uncertain significance (Oct 17, 2023) | ||
3-51978353-G-C | not specified | Uncertain significance (Jan 24, 2023) | ||
3-51978356-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
3-51980441-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
3-51980462-C-T | not specified | Likely benign (Jan 10, 2023) | ||
3-51980578-G-C | not specified | Uncertain significance (Oct 13, 2023) | ||
3-51980879-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
3-51980882-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
3-51980893-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
3-51980902-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
3-51980915-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
3-51980936-G-C | not specified | Uncertain significance (Feb 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABHD14A-ACY1 | protein_coding | protein_coding | ENST00000463937 | 16 | 14134 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.77e-10 | 0.615 | 125600 | 0 | 148 | 125748 | 0.000589 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.237 | 274 | 285 | 0.960 | 0.0000176 | 3272 |
Missense in Polyphen | 110 | 130.04 | 0.84588 | 1472 | ||
Synonymous | 0.443 | 108 | 114 | 0.947 | 0.00000687 | 1056 |
Loss of Function | 1.36 | 19 | 26.6 | 0.715 | 0.00000117 | 310 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00182 | 0.00181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00229 | 0.00229 |
Finnish | 0.0000960 | 0.0000924 |
European (Non-Finnish) | 0.000468 | 0.000466 |
Middle Eastern | 0.00229 | 0.00229 |
South Asian | 0.000329 | 0.000327 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Pathway
- Arginine biosynthesis - Homo sapiens (human)
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0814
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.470
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis;cellular amino acid metabolic process
- Cellular component
- cytoplasm
- Molecular function
- aminoacylase activity;metallopeptidase activity